These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 9864262
1. Effects of 5-hydroxytryptamine2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine. O'Neill MF, Hicks CA, Shaw G, Parameswaran T, Cardwell GP, O'Neill MJ. J Pharmacol Exp Ther; 1998 Dec; 287(3):839-46. PubMed ID: 9864262 [Abstract] [Full Text] [Related]
2. Regulation of c-Fos and NGF1-A by antidepressant treatments. Morinobu S, Strausbaugh H, Terwilliger R, Duman RS. Synapse; 1997 Apr; 25(4):313-20. PubMed ID: 9097389 [Abstract] [Full Text] [Related]
3. Effects of acute and chronic administration of MK-801 on c-Fos protein expression in mice brain regions implicated in schizophrenia with or without clozapine. Zuo DY, Cao Y, Zhang L, Wang HF, Wu YL. Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar 17; 33(2):290-5. PubMed ID: 19121361 [Abstract] [Full Text] [Related]
4. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol. Yanahashi S, Hashimoto K, Hattori K, Yuasa S, Iyo M. Brain Res; 2004 Jun 11; 1011(1):84-93. PubMed ID: 15140647 [Abstract] [Full Text] [Related]
5. Competitive and non-competitive NMDA receptor antagonists induce c-Fos expression in the rat anterior, cingulate cortex. Wedzony K, Czyrak A. J Physiol Pharmacol; 1996 Sep 11; 47(3):525-33. PubMed ID: 8877908 [Abstract] [Full Text] [Related]
6. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum. Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D. Eur J Pharmacol; 2009 Oct 12; 620(1-3):27-35. PubMed ID: 19695244 [Abstract] [Full Text] [Related]
7. Nicotine and clozapine actions on pre-pulse inhibition deficits caused by N-methyl-D-aspartate (NMDA) glutamatergic receptor blockade. Levin ED, Petro A, Caldwell DP. Prog Neuropsychopharmacol Biol Psychiatry; 2005 May 12; 29(4):581-6. PubMed ID: 15866361 [Abstract] [Full Text] [Related]
8. Role of adenosine and N-methyl-D-aspartate receptors in mediating haloperidol-induced gene expression and catalepsy. Chartoff EH, Ward RP, Dorsa DM. J Pharmacol Exp Ther; 1999 Nov 12; 291(2):531-7. PubMed ID: 10525068 [Abstract] [Full Text] [Related]
9. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. Bakshi VP, Swerdlow NR, Geyer MA. J Pharmacol Exp Ther; 1994 Nov 12; 271(2):787-94. PubMed ID: 7965797 [Abstract] [Full Text] [Related]
10. Clozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801 Clz and MK-801 in KO1A mice. Scorza MC, Castañé A, Bortolozzi A, Artigas F. Neuropharmacology; 2010 Nov 12; 59(1-2):112-20. PubMed ID: 20412811 [Abstract] [Full Text] [Related]
11. Suppressive effect of clozapine but not haloperidol on the increases of neuropeptide-degrading enzymes and glial cells in MK-801-treated rat brain regions. Arif M, Chikuma T, Ahmed MM, Yoshida S, Kato T. Neurosci Res; 2007 Feb 12; 57(2):248-58. PubMed ID: 17141345 [Abstract] [Full Text] [Related]
12. Molecular mechanisms in dizocilpine-induced attenuation of development of morphine dependence: an association with cortical Ca2+/calmodulin-dependent signal cascade. Hamdy MM, Noda Y, Miyazaki M, Mamiya T, Nozaki A, Nitta A, Sayed M, Assi AA, Gomaa A, Nabeshima T. Behav Brain Res; 2004 Jul 09; 152(2):263-70. PubMed ID: 15196794 [Abstract] [Full Text] [Related]
13. Pharmacological studies with two new ergoline derivatives, the potential antipsychotics LEK-8829 and LEK-8841. Krisch I, Bole-Vunduk B, Pepelnak M, Lavric B, Ocvirk A, Budihna MV, Sket D. J Pharmacol Exp Ther; 1994 Oct 09; 271(1):343-52. PubMed ID: 7965734 [Abstract] [Full Text] [Related]
14. Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats. Bakshi VP, Tricklebank M, Neijt HC, Lehmann-Masten V, Geyer MA. J Pharmacol Exp Ther; 1999 Feb 09; 288(2):643-52. PubMed ID: 9918570 [Abstract] [Full Text] [Related]
15. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol. Gaisler-Salomon I, Weiner I. Psychopharmacology (Berl); 2003 Apr 09; 166(4):333-42. PubMed ID: 12599023 [Abstract] [Full Text] [Related]
16. Chronic high-dose haloperidol has qualitatively similar effects to risperidone and clozapine on immediate-early gene and tyrosine hydroxylase expression in the rat locus coeruleus but not medial prefrontal cortex. Verma V, Lim EP, Han SP, Nagarajah R, Dawe GS. Neurosci Res; 2007 Jan 09; 57(1):17-28. PubMed ID: 17028028 [Abstract] [Full Text] [Related]
17. Clozapine-, but not haloperidol-, induced increases in deltaFosB-like immunoreactivity are completely blocked in the striatum of mice lacking D3 dopamine receptors. Robertson GS, Lee CJ, Sridhar K, Nakabeppu Y, Cheng M, Wang YM, Caron MG. Eur J Neurosci; 2004 Dec 09; 20(11):3189-94. PubMed ID: 15579174 [Abstract] [Full Text] [Related]
18. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine. Arvanov VL, Wang RY. J Pharmacol Exp Ther; 1999 May 09; 289(2):1000-6. PubMed ID: 10215680 [Abstract] [Full Text] [Related]
19. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598). Megens AA, Awouters FH, Meert TF, Schellekens KH, Niemegeers CJ, Janssen PA. J Pharmacol Exp Ther; 1992 Jan 09; 260(1):146-59. PubMed ID: 1370538 [Abstract] [Full Text] [Related]
20. Effects of antipsychotic drugs on neurotoxicity, expression of fos-like protein and c-fos mRNA in the retrosplenial cortex after administration of dizocilpine. Fujimura M, Hashimoto K, Yamagami K. Eur J Pharmacol; 2000 Jun 09; 398(1):1-10. PubMed ID: 10856442 [Abstract] [Full Text] [Related] Page: [Next] [New Search]